The present invention generally relates to catheters and preferably to multi-lumen catheters used for vascular access.
Multi-lumen catheters and, in particular split-tip catheters, are desirable for various treatment applications such as hemodialysis where fluid extraction and return occur simultaneously. Hemodialysis is the separation of metabolic waste products and water from the blood by filtration. Typically, a hemodialysis unit is connected to a patient's body by a catheter. The catheter's distal end is placed in a blood vessel and its proximal end is connected to a hemodialysis unit.
During hemodialysis, a patient's blood typically flows through a double lumen catheter to the hemodialysis unit which provides filtration and controls the flow of blood. A double lumen catheter has two lumens that independently allow fluid extraction and return. For example, one lumen can be used for removing blood from a patient for processing in the hemodialysis machine and the other lumen can be used for subsequently returning the processed blood back to the patient's circulatory system. Such catheters can also include additional lumens for flushing, administration of anticoagulants or the like.
Parameters that can be varied to achieve adequate hemodialysis include blood flow rate, dialysis solution flow rate, and dialyzer competency. Generally, raising the blood flow rate increases dialysis efficiency. However, conditions such as access recirculation decrease efficiency. Access recirculation is the recirculation of treated blood back into the hemodialysis unit. Excess recirculation effectively reduces dialysis efficiency and lengthens the duration of the treatment needed for adequate dialysis. Access recirculation can be particularly of concern when using a double lumen catheter due to the close proximity of the intake and outflow ports at the distal tip of the catheter.
Various double lumen catheter designs have been suggested for the purpose of reducing access recirculation. The distal ends of intake and outflow lumens have been longitudinally spaced 20-30 mm apart to prevent recirculation. For example, Twardowski et al. U.S. Pat. No. 5,569,182 discloses that the lumen for return of blood back into the vein should terminate beyond the extraction lumen. The purpose of this is to prevent cleansed blood, exiting from the outlet point of the catheter, from re-entering the catheter's blood inlet point and returning to the dialysis machine. However, certain disadvantages have been noted by such large longitudinal spacing between the distal ends of the respective lumens. For example, blood flow stagnation in the region of the blood vessel between two widely separated tips can lead to clot formation.
In addition to longitudinal spacing of the distal openings of the lumens, others have suggested that the distal end of a multi-lumen catheter can be split such that the distal tip segments can independently move in the blood vessel to optimize the fluid dynamics of the different functions (blood extraction and blood return). The introduction of an angle between the extraction and return lumens of a split tip catheter can further reduce the likelihood of access recirculation due to greater separation between inflow and outflow lumens.
Moreover, it can be desirable to have the maximum possible luminal cross-sectional areas to optimize catheter flow characteristics and also to maintain adequate flow over time since flow rates tend to decrease due to factors such as catheter clotting. However, a need can remain to maintain adequate physical and mechanical properties of the catheter, for instance tensile strength and kink-resistance, and to keep overall catheter dimensions small enough for insertion and proper physiological function. With these constraints in mind, it can be advantageous to have a different shape, e.g., greater luminal cross-section, for one or the other of the lumens or split tip segments, for example, to facilitate blood withdrawal or to diffuse returning cleansed blood. In particular, the arterial (or extraction) lumen is more prone to clogging and can benefit from having a larger cross-section. However, such geometric differences are difficult to incorporate into split-tip catheters using conventional manufacturing techniques.
While various techniques are known for manufacturing split tip catheters, there exists a need for more efficient and more robust techniques, especially in manufacturing split tip catheters when the divergence of the tip elements at an angle is desired or a different shape or geometry is desired for one or the other of the lumens or tip segments.
Multi-lumen catheter devices having at least one split end are disclosed, together with methods of forming such split tip catheters. In one aspect of the invention, the manufacturing methods can include the steps of: providing a catheter body having at least a first and a second internal lumen extending longitudinally through the catheter body; removing a distal portion of the catheter body to form a first distal tip segment such that the first lumen extends longitudinally within this tip segment beyond the second lumen; and joining a second lumen tip segment to the catheter body in communication with the second lumen. The second tip segment can be joined to the catheter body such that it is at least partially separated from the first tip segment and, in some embodiments, preferably diverges at an angle relative to the first tip segment.
The second lumen tip segment can be joined to the device by various techniques. For example, the second segment can be joined to the catheter body by thermal or chemical fusion. Alternatively, the second lumen tip segment can be bonded to the catheter body with an adhesive or the like.
In one embodiment of the invention, the second lumen tip segment can be oriented such that the first and second tip segments are separate and diverge from each other at an angle. The angle between the first and second tip segments can be formed before, during, or after the second tip segment is joined to the catheter body. For example, the angle can be formed after joining the segment to the catheter body by the application of heat. Alternatively, the catheter body and/or the second segment can present an angled interface such that an angle is formed at the joint itself. The angle between the first and second tip segments can change from a proximal end of the first and second tip segments to a distal end of the first and second tip segments, e.g., one or both of the separate tip segments can be a compound angle or formed in the shape of a simple or compound curve.
In another embodiment of the invention, the second lumen tip segment can be oriented such that the first and second tip segments are separate but substantially parallel to each other.
Split tip catheters according to the invention can be formed by removing a distal portion of the catheter body by slicing away one of the lumens. If an angled separation is desired, the method can further include trimming the lumen in a non-perpendicular direction with respect to a longitudinal axis of the catheter body to facilitate attachment of the second tip segment at an angle. Alternatively, if substantially parallel split tips are desired, the method can further include trimming the lumen in a direction that is substantially perpendicular to a longitudinal axis of the trimmed lumen.
The catheters of the present invention can further include forming fluid passage holes in a side of at least one of the tip segments. In another aspect, the catheters of the present invention can further include coatings of at least a portion of the catheter body or the first and/or second tip segments with an antithrombotic agent, such as heparin, to reduce blood clotting or protein adhesion. In other aspects, the catheters of the present invention can include coatings of at least a portion of the body or the first and/or second tip segments with an antibacterial agent and/or an anti-inflammatory agent.
Additionally, following (or during) formation of the split tip catheter, the first and second tip segments can be joined together with a bioresorbable adhesive to simplify vascular insertion. Following insertion, the tip segments can separate upon dissolution of the adhesive, e.g., over a period of time ranging from 1 second to several days, more preferably from about 1 minute to about 10 hours, or 5 hours or one hour.
In another aspect of the invention, a method of forming a split tip catheter is disclosed including the steps of: (a) providing a multi-lumen catheter having at least a first inner lumen and a second inner lumen extending therethrough; (b) partially truncating a distal end of the multi-lumen catheter body to form a first distal lumen tube such that the first lumen of the catheter within the first distal tube longitudinally extends further than at least a second lumen of the catheter; and (c) attaching a second lumen tube to the severed end of the catheter such that a second distal lumen tube in fluid communication with the second lumen of the catheter is formed and extends longitudinally from the catheter separate from the first distal lumen tube.
The method can further include forming a non-zero angle between the first distal tube and the second distal tube. A non-zero-angle can be formed, for example, by trimming the catheter body at an angle, e.g., in a non-perpendicular direction with respect to a longitudinal axis of the first distal lumen tube, and then fusing or bonding the second distal tube to the catheter body at this location. The term “fusing” is used interchangeably with “bonding” herein and, as used, both terms are intended to encompass thermal fusion, melt bonding, ultrasonic welding, chemical bonding, adhesive bonding and the like.
Alternatively, the first and second distal end tubes can be formed with substantially a zero angle of divergence, e.g., the two end segments are substantially parallel to each other in a rest position. A zero-angle can be formed, for example, by trimming the catheter body in a perpendicular direction with respect to a longitudinal axis of the first distal lumen tube, and then fusing or bonding the second distal tube to the catheter body at this location.
In certain embodiments, it may be preferable that the second distal tube (that is to be joined to the catheter body) have a different luminal cross-section than the second lumen within the catheter body or that the first and second lumens within the catheter body have a different luminal cross-section from one another. The invention is also applicable to catheters having three or more lumens. For example, a three lumen catheter body can be truncated such that only one distal lumen extends from the point of truncation and then two separate end tubes can be grafted onto the body to provide three independent distal tip segments. Alternatively, the two grafted segments can be attached together but joined to the body separately from the first segment (formed from the original catheter body). In another alternative, the three lumen catheter body can be truncated such that two of the lumens extend in a distal segment from the point of truncation with a separate end tube grafted onto the body to provide a separated third lumen.
The present invention is advantageous, among other reasons, because only one distal tip segment is bonded to the catheter body (in contrast to prior art where two tip segments must be bonded), thus simplifying the process and shortening the manufacturing time. A further advantage is that bonding a single distal tip segment permits reduced septum thickness in the catheter body (and therefore increased luminal cross-sections) since the septum does not have to accommodate the attachment of two separate distal end tubes.
The method is particularly useful when one or more of the lumens has a non-circular cross-section, e.g., a substantially D-shaped cross-section. For example, the catheter body can be formed in a “double-D” configuration, with two “D” shaped lumens back-to-back and separated by a septum. A catheter body with a septum between the lumens can be formed by various means, e.g., as an integral body by extrusion or by assembling two D-shaped single lumen elements and then surrounding them by a sheath of heat-shrink polymeric material, thereby forming an integral body.
The method according to the invention can further include the step of partially truncating the catheter body further comprises truncating the body at a truncation point such that at least a portion of the septum (and preferably a major portion or all of the septum) is retained by the first distal lumen tube. Moreover, the method can further include attaching the second distal tube at least partially to the septum of the first distal tube.
The method according to the invention can further include the step of attaching a second distal tube that has a different shape than the first or second lumens of the catheter body. (The term “shape” is used herein to encompass differences in geometry, e.g., circular, ellipsoid or D-shaped as well as differences in size, e.g., cross-sectional area of the lumens.)
In another aspect of the invention, a method of forming a split tip catheter is disclosed, wherein the method can include the steps of: (a) truncating the catheter body at a septum dividing two of the lumens such that a first distal end tube is formed and the first tube surrounds a first lumen having a length that extends beyond a truncation point; and (b) attaching a second distal end lumen tube to the catheter body in fluid communication with a second lumen of the catheter body.
In yet another aspect of the invention, another method of forming a split tip catheter is disclosed including the steps of: (a) removing a partial length of a lumen included in a catheter body to expose a septum between the lumen and another lumen included in the catheter body, wherein each lumen defines a separate fluid pathway extending longitudinally through the body; and (b) attaching a replacement lumen tube at a distal end of the catheter body such that a pathway extending longitudinally through the replacement lumen tube is in communication with the pathway of the lumen that was partially removed. Again, the two (or more) lumen tubes can be formed to either diverge at an angle or to remain parallel to each other. (The term “parallel,” as used herein, is intended to encompass configurations that nominally have a “zero” angle of divergence as well as slight angles that may exist due to practical constraints or machining tolerances. It should also be appreciated that the preferred materials for the catheters of this invention are polymeric materials, such as polyurethane or silicone, that will also exhibit flexibility or “floppiness,” in both their parallel and divergence configurations.)
The step of removing the partial length of the lumen can further include trimming the lumen opening at a zero or non-zero angle in relation to an axis perpendicular to a longitudinal axis of the catheter. The end of the replacement lumen tube to be joined to the catheter body can also be cut at an angle.
In another aspect of the invention, a method of forming a split tip catheter is disclosed including the steps of: (a) providing a multi-lumen catheter body having at least a first inner lumen and a second inner lumen extending therethrough; (b) partially truncating the multi-lumen catheter body such that a first distal lumen tube is formed to longitudinally extend the first lumen of the catheter further than at least the second lumen of the catheter; and (c) attaching a second lumen tube to the truncated end of the catheter such that a pathway separate from the first distal tube is formed in fluid communication with the second lumen of the catheter, wherein the first inner lumen has a different shape than the second inner lumen.
In a further aspect of the invention, split tip catheter devices are disclosed. In one embodiment the split tip catheter can include a catheter body; a first lumen included in the catheter body, the first lumen having an inner pathway extending longitudinally through the catheter body; a second lumen included in the catheter body, the second lumen having an inner pathway extending longitudinally through the catheter body and a length less than a length of the first lumen; and a lumen tip segment attached to the second lumen and having a pathway extending longitudinally through the lumen tip segment such that the pathway of the lumen tip segment is in communication with the pathway of the second lumen.
Catheter devices according to the invention can be formed such that at least a part of one of the lumen tip segments is composed of a material different than a material of the catheter body. In certain embodiments, the first lumen and the lumen tip segment are separate and diverge from each other at an angle at a distal end of the catheter body. In other embodiments, the first lumen and the lumen tip segment are separate but substantially parallel to each other.
In yet another embodiment, a split tip catheter device is disclosed including a catheter body; a first distal tip segment integral with the catheter body, the first distal segment having an inner pathway extending longitudinally through a first lumen of the catheter body; and a second distal tip segment separate from the first distal segment and joined to the catheter body to provide a fluid pathway from a second lumen of the catheter body and extending longitudinally through the second tip segment.
Other advantages and features will become apparent from the following description and from the claims.
The invention will be more fully understood from the following detailed description taken in conjunction with the accompanying drawings, in which like reference numerals designate like parts throughout the figures, and wherein:
In
The catheter body 102 can include an outer sheath 122 which partially or entirely covers and encloses the lumens 104. The outer sheath 122 can be any shape and size and can be made of the same material as the lumens 104 or other material compatible with insertion into a blood vessel. As illustrated in this embodiment, the outer sheath 122 terminates proximal to the distal ends 116 of the lumens 104 such that the lumen tips 110 of each lumen 104 are separate or can separate from one another after being inserted into a blood vessel.
The lumens 104 can have a variety of cross-sectional shapes and sizes but preferably, as shown in the embodiment in
The lumens 104 can be made of any biocompatible material, including any material which allows the lumen tips 110, 114 of the lumens 104 to be flexible and facilitate hemodialysis. Furthermore, the lumen tip segment 114 can be made from a material different from a material of the cut lumen 104b. The different material can be one more or less flexible than the material of the cut lumen 104b. Using different materials for the lumen tip segment 114 and the cut lumen 104b can allow the catheter body 102 to be used more efficiently or to be used at all in an application where it would not be preferable or possible having material of the cut lumen 104b at the distal end 116b.
The distal extraction and return tip portions 110 of each lumen 104 include pathways 106 formed therein for the extraction or return of blood or other bodily fluids. The pathways 106 are preferably sized to allow the carrying of blood to and from a hemodialysis unit, although the pathways 106 can be any size and the catheter 100 can be used in any application. The distal extraction and return tip portions 110 can be the same length or, as discussed further below, can be different lengths.
An exemplary method of forming a split tip catheter is described with reference to
The sacrificed lumen 104a can be trimmed in a variety of ways. In a preferred example, one of the lumens 104b can be sliced (e.g., cut or scored) widthwise across its circumference at a location 124. Then a length L1 of the cut lumen 104b can be trimmed from the catheter body 102. When the length L1 of the cut lumen 104b has been removed, a septum between the cut lumen 104b and the uncut lumen 104a can thereby be at least partially exposed.
Referring again to
In certain applications it can be preferable to sacrifice the smaller lumen 104a instead. In such instances, the truncation line can be moved to the other side of the septum 202.
Dimensions of the lumens 104a and 104b can vary between embodiments. In this example embodiment, dimensions allow the catheter body 102 to be used with standard hemodialysis equipment and lumen tip segments. Maximum width w2 of the smaller lumen pathway 106b is about 0.06 in. and maximum width w1 of the larger lumen pathway 106a is about 0.08 in. The septum 202 has a width w3 of about 0.02±0.002 in., while the lumens 104 have an exterior width w4 of about 0.022±0.003 in. Maximum height h2 of the smaller pathway 106a is about 0.14 in. and maximum height h1 of the larger pathway 106b is about 0.15 in.
The cut distal end 124 of the cut lumen 104b can be trimmed in a perpendicular direction or a non-perpendicular direction with respect to a longitudinal axis β of the cut lumen 104b.
With a distal portion of the catheter body 102 removed, the lumen tip segment 114 can be joined to the catheter body 102 as shown in
The lumen tip segment 114 can be attached to the catheter body 102 in a variety of ways. For example, the lumen tip segment 114 can be fused to the lumen tip 110b at the cut distal end 124. Any fusion technique can be used, e.g., thermal fusion where elements to be joined (here, the lumen tip segment 114 and the lumen tip 110b) are heated along any or all portions of their perimeters or other areas to a desired temperature and fused together by application of a desired force or by inserting one lumen tube over the other (e.g., with an overlap by about 1 cm) and allowing them to melt/cool together. In another example, the lumen tip segment 114 can be bonded to the lumen tip 110b at the cut distal end 124. Any bonding technique can be used, e.g., applying a bonding material such as an adhesive to one or more of the elements to be bonded and, if necessary, heating the bonding material to bond it to the elements. In some embodiments, the lumen tip segment 114 can be attached in such a way as to provide a gradual transition between the luminal walls of the catheter body 102 and the luminal walls of the lumen tip segment 114, for instance via the insertion of a mandrel and the application of heat.
The lumen tip segment 114 can be oriented at any angle with respect to the longitudinal axis β of the cut lumen 104b. Moreover, one or both of the lumen tip segment 114 and the lumen tip 110a can have a convex shape with respect to the other tip over at least some portion of its length. For example, the lumen tip segment 114 can be attached to the lumen tip 110b at a ninety degree angle θ′ with respect to axis β as shown in
The apex of angle σ can be located either at the junction of the cut lumen 104b and the lumen tip segment 114, as shown in
Whether substantially parallel or diverging from one another, the lumens 104 are separate (at least before application of any adhesive, discussed further below).
Referring again to
The bioresorbable adhesive 1600 used to join the lumen tips 110 of the lumens 104 to one another can be a composition selected from the group of polymers consisting of polylactides, polyglycolides, polylactones, polyorthoesters, polyanhydrides, and copolymers and combinations thereof. In general, bioresorbable adhesives have bonding elements and degradable elements. The degradable elements can have the components of polylactide, polyglycolide and polylactones (polycaprolactone). The bonding elements can have hydrogen bonding strength (polyvinyl alcohol, polysaccharides) or can be able to polymerize as a single component (cyanoacrylates) or as two components (epoxy compound plus amino compounds, or radical (light) initiators of acrylate compounds).
Proteins, sugars, and starch can also be used as an adhesive. By way of non-limiting example, antithrombotic agents such as heparin and hirudin, citrate, antithrombin-heparin complex, and albumin heparin complex as well as anti-infective agents such as chlorohexidine, silver, antibiotics, and antiseptic agents may be added to the adhesive.
In an embodiment of the present invention, polymers which can be useful include polyurethane, generally described as a copolymer of polyethylene glycol with polylactide or polyglycolide end capped with methacrylates. Another embodiment can include a two component composition, one component preferably including a low molecular weight polyurethane end capped with methacrylates, and the other component preferably including polylactide, polyglycolide, or polycaprolactone end capped with methacrylate.
In another embodiment of the present invention, one or more components can be used from styrene, methyl methacrylate, methyl acrylate, ethylene dimethacrylate, ethylene diacrylate, acrylamide, diurethane dimethacrylate, polyisoprenegraft-maleic acid monomethyl ester, azobis (cyanovaleric acid), azobiscyclohexanecarbonitrile, azobisisobutyronitrile, benzoyl peroxide, iron (II) sulfate, polyvinyl alcohol, dextran, polysaccharide, epichlorohydrin, ethylenediamine, diaminocyclohexane, diamino propane, copolymers with polylactide and polyethylene oxide as the blocks and acrylate, methacrylate as the end groups, cyanoacrylates, ethyl-2cyanoacrylate, propyl-2-cyanoacrylates, pentyl-2-cyanoacrylate, hexyl-2-cyanoacrylate, and octyl-2-cyanoacrylate, ammonium persulfate and/or polyethylene glycol methacrylate when water, organic solvent such as dichloromethane, chloroform, tetrahydrofuran, acetone, petroleum ether, acetyl acetate, dirnethylformamide, or the mixture thereof, is combined with the aforementioned solvents.
As shown in
In an embodiment shown in
In the embodiments described herein, the bioresorbable adhesive preferably dissolves after insertion into a blood vessel to provide separation of the lumen tips 110 of the lumens 104 in a time period ranging from one minute to one hour (but as long as several days or longer). This range can be controlled by using different compositions of the bioresorbable adhesive as well as by the amount of adhesive applied to join the lumen tips 110 of the lumens 104 together.
In another embodiment with opposed distal fluid openings 112 (further described below), the bioresorbable adhesive can be water soluble such that the introduction of saline or similar type fluid will effectuate the separation of the lumen tips 110 of the lumens 104. In this instance, the bioresorbable adhesive will not dissolve until a time after the introduction of the soluble solution into the lumens 104.
The distal fluid openings 112a can be any shape and size and can be located in a variety of places on the lumen 104a.
The above embodiments describe a split distal end of a catheter, but in addition to or instead of splitting the distal end, the proximal end can also be formed in a split tip configuration in any way described above with respect to the distal end (e.g., in a double split-tip or “double-Y” configuration). Such a configuration can be useful in retrograde or reverse insertions where the catheter body is passed through a subcutaneous tunnel from venotomy site to the remote exit location. After tunneling the catheter, fluid couplings or other attachments can be disposed to the proximal end of the lumens.
Other embodiments are within the scope of the following claims.
All publications, patent documents and other information sources identified in this application are hereby incorporated by reference.
This application claims the benefit of priority to U.S. Provisional Application No. 60/980,633, filed Oct. 17, 2007, and titled “Manufacture of Split Tip Catheters,” which is incorporated by reference in its entirety herein. The following three applications, filed concurrently herewith, are related to the subject matter of this application and are incorporated by reference in their entirety herein: 1) U.S. patent application Ser. No. 12/244,554, titled “Catheters With Enlarged Arterial Lumens,” and published as US 2009/0204079; 2) U.S. patent application Ser. No. 12/244,544, titled “Fusion Manufacture of Multi-Lumen Catheters,” and published as US 2009/0209940; and 3) U.S. patent application Ser. No. 12/244,559, titled “Manufacture of Fixed Tip Catheters,” and published as US 2009/0205189.
Number | Name | Date | Kind |
---|---|---|---|
701075 | McCully | May 1902 | A |
1696018 | Scheliberg | Dec 1928 | A |
1856811 | Inaki | May 1932 | A |
2024982 | Scott | Dec 1935 | A |
2173527 | Agayoff | Sep 1939 | A |
2286462 | Chaffin | Jun 1942 | A |
2393002 | Smith | Jan 1946 | A |
2910981 | Wilson et al. | Nov 1959 | A |
3144868 | Jascalevich | Aug 1964 | A |
3176690 | H'Doubler | Apr 1965 | A |
3256885 | Higgins et al. | Jun 1966 | A |
3416532 | Grossman | Dec 1968 | A |
3426759 | Smith | Feb 1969 | A |
3460255 | Hutson | Aug 1969 | A |
D217795 | Spaven | Jun 1970 | S |
3612038 | Halligan | Oct 1971 | A |
3736939 | Taylor | Jun 1973 | A |
3805794 | Schlesinger | Apr 1974 | A |
3812851 | Rodriguez | May 1974 | A |
3848604 | Sackner | Nov 1974 | A |
3890977 | Wilson | Jun 1975 | A |
3929126 | Corsaut | Dec 1975 | A |
3935857 | Co | Feb 1976 | A |
3995623 | Blake et al. | Dec 1976 | A |
4068659 | Moorehead | Jan 1978 | A |
4072146 | Howes | Feb 1978 | A |
4072153 | Swartz | Feb 1978 | A |
4098275 | Consalvo | Jul 1978 | A |
4114625 | Onat | Sep 1978 | A |
4117836 | Erikson | Oct 1978 | A |
4129129 | Amrine | Dec 1978 | A |
4134402 | Mahurkar | Jan 1979 | A |
4149535 | Volder et al. | Apr 1979 | A |
4180068 | Jacobsen et al. | Dec 1979 | A |
4248224 | Jones | Feb 1981 | A |
4276880 | Malmin | Jul 1981 | A |
4292976 | Banka | Oct 1981 | A |
4299228 | Peters | Nov 1981 | A |
4300550 | Gandi et al. | Nov 1981 | A |
4309994 | Grunwald | Jan 1982 | A |
4327722 | Groshong et al. | May 1982 | A |
4385631 | Uthmann | May 1983 | A |
4392855 | Oreopoulos et al. | Jul 1983 | A |
4403983 | Edelman et al. | Sep 1983 | A |
4405313 | Sisley et al. | Sep 1983 | A |
4406656 | Hattler et al. | Sep 1983 | A |
D272651 | Mahurkar | Feb 1984 | S |
4431426 | Groshong et al. | Feb 1984 | A |
4432722 | Bohan, Jr. et al. | Feb 1984 | A |
4432752 | Marlon | Feb 1984 | A |
4445893 | Bodicky | May 1984 | A |
4451252 | Martin | May 1984 | A |
4453928 | Steiger | Jun 1984 | A |
4465482 | Tittel et al. | Aug 1984 | A |
4490138 | Lipsky et al. | Dec 1984 | A |
4493696 | Uldall | Jan 1985 | A |
RE31873 | Howes | Apr 1985 | E |
4531933 | Norton et al. | Jul 1985 | A |
4543087 | Sommercorn et al. | Sep 1985 | A |
4545373 | Christoudias | Oct 1985 | A |
4557261 | Rugheimer et al. | Dec 1985 | A |
4568329 | Mahurkar | Feb 1986 | A |
4568338 | Todd | Feb 1986 | A |
4573476 | Ruiz | Mar 1986 | A |
4581012 | Brown et al. | Apr 1986 | A |
4583968 | Mahurkar | Apr 1986 | A |
4583986 | Lapidus | Apr 1986 | A |
4601697 | Mammolenti et al. | Jul 1986 | A |
4619643 | Bai | Oct 1986 | A |
4623327 | Mahurkar | Nov 1986 | A |
4626240 | Edelman et al. | Dec 1986 | A |
4642101 | Krolikowski et al. | Feb 1987 | A |
4643711 | Bates | Feb 1987 | A |
4666426 | Aigner et al. | May 1987 | A |
4668221 | Luther | May 1987 | A |
4670009 | Bullock | Jun 1987 | A |
4675004 | Hadford et al. | Jun 1987 | A |
4681122 | Winters et al. | Jul 1987 | A |
4681564 | Landreneau | Jul 1987 | A |
4681570 | Dalton | Jul 1987 | A |
4682978 | Martin | Jul 1987 | A |
4687471 | Twardowski et al. | Aug 1987 | A |
4692141 | Mahurkar | Sep 1987 | A |
4694838 | Wijayarthna et al. | Sep 1987 | A |
4701159 | Brown et al. | Oct 1987 | A |
4702917 | Schindler | Oct 1987 | A |
4713171 | Polaschegg | Dec 1987 | A |
4717379 | Ekholmer et al. | Jan 1988 | A |
4735620 | Ruiz | Apr 1988 | A |
4737141 | Spits | Apr 1988 | A |
4737152 | Alchas | Apr 1988 | A |
4738667 | Galloway | Apr 1988 | A |
4748808 | Hill | Jun 1988 | A |
4755176 | Patel | Jul 1988 | A |
4769016 | Labianca et al. | Sep 1988 | A |
4770652 | Mahurkar | Sep 1988 | A |
4772268 | Bates | Sep 1988 | A |
4772269 | Twardowski et al. | Sep 1988 | A |
4776841 | Catalano | Oct 1988 | A |
4777951 | Cribier et al. | Oct 1988 | A |
4784638 | Ghajar et al. | Nov 1988 | A |
4790809 | Kuntz | Dec 1988 | A |
4795439 | Guest | Jan 1989 | A |
4801297 | Mueller | Jan 1989 | A |
4804359 | Grunwald et al. | Feb 1989 | A |
4808155 | Mahurkar | Feb 1989 | A |
4808163 | Laub | Feb 1989 | A |
4809710 | Williamson | Mar 1989 | A |
4820265 | DeSatnick et al. | Apr 1989 | A |
4832687 | Smith, III | May 1989 | A |
4834709 | Banning et al. | May 1989 | A |
4842582 | Mahurkar | Jun 1989 | A |
4842592 | Caggiani et al. | Jun 1989 | A |
4846814 | Ruiz | Jul 1989 | A |
4863441 | Lindsay et al. | Sep 1989 | A |
4867742 | Calderon | Sep 1989 | A |
4892518 | Cupp et al. | Jan 1990 | A |
4894057 | Howes | Jan 1990 | A |
4895561 | Mahurkar | Jan 1990 | A |
4898591 | Jang et al. | Feb 1990 | A |
4906238 | Greenfeld et al. | Mar 1990 | A |
4925452 | Melinyshyn et al. | May 1990 | A |
4927418 | Dake et al. | May 1990 | A |
4935004 | Cruz | Jun 1990 | A |
4935010 | Cox et al. | Jun 1990 | A |
4935044 | Schoenpflug et al. | Jun 1990 | A |
4936826 | Amarasinghe | Jun 1990 | A |
4950232 | Ruzicka et al. | Aug 1990 | A |
4950259 | Geary et al. | Aug 1990 | A |
4951665 | Schneider | Aug 1990 | A |
4961729 | Vaillancourt | Oct 1990 | A |
4961731 | Bodicky et al. | Oct 1990 | A |
4961809 | Martin et al. | Oct 1990 | A |
4968307 | Dake et al. | Nov 1990 | A |
4969890 | Sugita et al. | Nov 1990 | A |
4981477 | Schon et al. | Jan 1991 | A |
4985014 | Orejola | Jan 1991 | A |
4990138 | Bacich et al. | Feb 1991 | A |
4994027 | Farrell | Feb 1991 | A |
4995865 | Gahara et al. | Feb 1991 | A |
5009636 | Wortley et al. | Apr 1991 | A |
5015230 | Martin et al. | May 1991 | A |
5016640 | Ruiz | May 1991 | A |
5021044 | Sharkawy | Jun 1991 | A |
5041101 | Seder et al. | Aug 1991 | A |
5041107 | Heil, Jr. | Aug 1991 | A |
5049138 | Chevalier et al. | Sep 1991 | A |
5053003 | Dadson et al. | Oct 1991 | A |
5053004 | Markel et al. | Oct 1991 | A |
5053023 | Martin | Oct 1991 | A |
5057073 | Martin | Oct 1991 | A |
5059170 | Cameron | Oct 1991 | A |
5069673 | Shwab | Dec 1991 | A |
5074841 | Ademovic et al. | Dec 1991 | A |
5084013 | Takase et al. | Jan 1992 | A |
5098412 | Shiu | Mar 1992 | A |
5100395 | Rosenberg | Mar 1992 | A |
5102402 | Dror et al. | Apr 1992 | A |
5106368 | Uldall et al. | Apr 1992 | A |
5106376 | Mononen et al. | Apr 1992 | A |
5111829 | Alvarez de Toledo | May 1992 | A |
5112301 | Fenton, Jr. et al. | May 1992 | A |
5114423 | Kasprzyk et al. | May 1992 | A |
5117836 | Millar | Jun 1992 | A |
5120299 | Lombardi | Jun 1992 | A |
5120304 | Sasaki | Jun 1992 | A |
5122125 | Deuss et al. | Jun 1992 | A |
5125904 | Lee | Jun 1992 | A |
5129891 | Young | Jul 1992 | A |
5135599 | Martin et al. | Aug 1992 | A |
5139486 | Moss | Aug 1992 | A |
5156592 | Martin et al. | Oct 1992 | A |
5163928 | Hobbs et al. | Nov 1992 | A |
5167623 | Cianci et al. | Dec 1992 | A |
5171216 | Dasse et al. | Dec 1992 | A |
5171227 | Twardowski et al. | Dec 1992 | A |
5178616 | Uemiya et al. | Jan 1993 | A |
5188592 | Hakki | Feb 1993 | A |
5188593 | Martin | Feb 1993 | A |
5190520 | Fenton, Jr. et al. | Mar 1993 | A |
5190529 | McCrory et al. | Mar 1993 | A |
5191898 | Millar | Mar 1993 | A |
5195962 | Martin et al. | Mar 1993 | A |
5197951 | Mahurkar | Mar 1993 | A |
5197973 | Pang et al. | Mar 1993 | A |
5197976 | Herweck et al. | Mar 1993 | A |
5201723 | Quinn | Apr 1993 | A |
5207648 | Gross | May 1993 | A |
5207650 | Martin | May 1993 | A |
5209723 | Twardowski et al. | May 1993 | A |
5209725 | Roth | May 1993 | A |
5209742 | Venema et al. | May 1993 | A |
5211256 | Muramatsu | May 1993 | A |
5215527 | Beck et al. | Jun 1993 | A |
5221255 | Mahurkar et al. | Jun 1993 | A |
5221256 | Mahurkar | Jun 1993 | A |
5222949 | Kaldany | Jun 1993 | A |
5226880 | Martin et al. | Jul 1993 | A |
5234438 | Semrad | Aug 1993 | A |
5236016 | Vogelsang et al. | Aug 1993 | A |
5242398 | Knoll et al. | Sep 1993 | A |
5246430 | MacFarlane | Sep 1993 | A |
5250034 | Appling et al. | Oct 1993 | A |
5254084 | Geary | Oct 1993 | A |
5273527 | Schatz et al. | Dec 1993 | A |
5273534 | Knoepfler | Dec 1993 | A |
5279596 | Castaneda et al. | Jan 1994 | A |
5279599 | Wilk | Jan 1994 | A |
5306240 | Berry | Apr 1994 | A |
5312337 | Flaherty et al. | May 1994 | A |
5312357 | Buijs et al. | May 1994 | A |
5318517 | Reiman | Jun 1994 | A |
5322519 | Ash | Jun 1994 | A |
5324274 | Martin | Jun 1994 | A |
5338308 | Wilk | Aug 1994 | A |
5342295 | Imran | Aug 1994 | A |
5342386 | Trotta | Aug 1994 | A |
5346471 | Raulerson | Sep 1994 | A |
5348536 | Young et al. | Sep 1994 | A |
5350358 | Martin | Sep 1994 | A |
5360397 | Pinchuk | Nov 1994 | A |
5360407 | Leonard et al. | Nov 1994 | A |
5364344 | Beattie et al. | Nov 1994 | A |
5374245 | Mahurkar | Dec 1994 | A |
5378230 | Mahurkar | Jan 1995 | A |
5380276 | Miller et al. | Jan 1995 | A |
5380290 | Makower et al. | Jan 1995 | A |
5382238 | Abrahamson et al. | Jan 1995 | A |
5389087 | Miraki | Feb 1995 | A |
5389090 | Fischell et al. | Feb 1995 | A |
5395316 | Martin et al. | Mar 1995 | A |
5399168 | Wadsworth, Jr. et al. | Mar 1995 | A |
5403291 | Abrahamson | Apr 1995 | A |
5405320 | Twardowski et al. | Apr 1995 | A |
5405341 | Martin | Apr 1995 | A |
5409463 | Thomas et al. | Apr 1995 | A |
5417668 | Setzer et al. | May 1995 | A |
5423768 | Folden et al. | Jun 1995 | A |
5431661 | Koch | Jul 1995 | A |
5451026 | Smith | Sep 1995 | A |
5451206 | Young | Sep 1995 | A |
5451233 | Yock | Sep 1995 | A |
5458570 | May, Jr. | Oct 1995 | A |
5458582 | Nakao | Oct 1995 | A |
5472417 | Martin et al. | Dec 1995 | A |
5472432 | Martin | Dec 1995 | A |
5476453 | Mehta | Dec 1995 | A |
5480380 | Martin | Jan 1996 | A |
5486159 | Mahurkar | Jan 1996 | A |
5489278 | Abrahamson | Feb 1996 | A |
5496292 | Burnham | Mar 1996 | A |
5505710 | Dorsey, III | Apr 1996 | A |
5507723 | Keshaviah | Apr 1996 | A |
5509897 | Twardowski et al. | Apr 1996 | A |
5509900 | Kirkman | Apr 1996 | A |
5509902 | Raulerson | Apr 1996 | A |
5542925 | Orth | Aug 1996 | A |
5545373 | Maziasz et al. | Aug 1996 | A |
5556390 | Hicks | Sep 1996 | A |
5556930 | Brehm et al. | Sep 1996 | A |
5558635 | Cannon | Sep 1996 | A |
5562609 | Brumbach | Oct 1996 | A |
5569182 | Twardowski et al. | Oct 1996 | A |
5569195 | Saab | Oct 1996 | A |
5571093 | Cruz et al. | Nov 1996 | A |
5584803 | Stevens et al. | Dec 1996 | A |
5599304 | Shaari | Feb 1997 | A |
5599328 | Stevens | Feb 1997 | A |
5607462 | Imran | Mar 1997 | A |
5624392 | Saab | Apr 1997 | A |
5624413 | Markel et al. | Apr 1997 | A |
5632729 | Cai et al. | May 1997 | A |
5637102 | Tolkoff et al. | Jun 1997 | A |
5642270 | Green et al. | Jun 1997 | A |
5662606 | Cimino et al. | Sep 1997 | A |
5665067 | Linder et al. | Sep 1997 | A |
5685867 | Twardowski et al. | Nov 1997 | A |
5686867 | Sutardja et al. | Nov 1997 | A |
5693030 | Lee et al. | Dec 1997 | A |
5695457 | St. Goar et al. | Dec 1997 | A |
5704915 | Melsky et al. | Jan 1998 | A |
5713849 | Bosma et al. | Feb 1998 | A |
5713853 | Clark et al. | Feb 1998 | A |
5717216 | McCoy et al. | Feb 1998 | A |
5718678 | Fleming, III | Feb 1998 | A |
5718692 | Schon et al. | Feb 1998 | A |
5720735 | Dorros | Feb 1998 | A |
5738649 | Macoviak | Apr 1998 | A |
5741329 | Agrawal et al. | Apr 1998 | A |
5743873 | Cai et al. | Apr 1998 | A |
5752939 | Makoto et al. | May 1998 | A |
5769796 | Palermo et al. | Jun 1998 | A |
5772643 | Howell et al. | Jun 1998 | A |
5776096 | Fields | Jul 1998 | A |
5776111 | Tesio | Jul 1998 | A |
5785686 | Runge | Jul 1998 | A |
5792094 | Stevens et al. | Aug 1998 | A |
5792123 | Ensminger | Aug 1998 | A |
5797869 | Martin et al. | Aug 1998 | A |
5800384 | Russell et al. | Sep 1998 | A |
5800414 | Cazal et al. | Sep 1998 | A |
5800516 | Fine et al. | Sep 1998 | A |
5807311 | Palestrant | Sep 1998 | A |
5807318 | St. Goar et al. | Sep 1998 | A |
5807329 | Gelman | Sep 1998 | A |
5809897 | Powell et al. | Sep 1998 | A |
5810789 | Powers et al. | Sep 1998 | A |
5814016 | Valley et al. | Sep 1998 | A |
5830184 | Basta | Nov 1998 | A |
5830196 | Hicks | Nov 1998 | A |
5833671 | Macoviak et al. | Nov 1998 | A |
5858009 | Jonkman | Jan 1999 | A |
5861010 | Boussignac et al. | Jan 1999 | A |
5868717 | Prosl | Feb 1999 | A |
5873865 | Horzewski et al. | Feb 1999 | A |
5876366 | Dykstra et al. | Mar 1999 | A |
5876426 | Kume et al. | Mar 1999 | A |
5882347 | Mouris-Laan et al. | Mar 1999 | A |
5891111 | Ismael et al. | Apr 1999 | A |
5904670 | Schreiner | May 1999 | A |
5911715 | Berg et al. | Jun 1999 | A |
5913848 | Luther et al. | Jun 1999 | A |
5916208 | Luther et al. | Jun 1999 | A |
5919160 | Sanfilippo, II | Jul 1999 | A |
5944732 | Raulerson et al. | Aug 1999 | A |
5947937 | Urrutia et al. | Sep 1999 | A |
5947953 | Ash et al. | Sep 1999 | A |
5957879 | Roberts et al. | Sep 1999 | A |
5957893 | Luther et al. | Sep 1999 | A |
5957912 | Heitzmann | Sep 1999 | A |
5961486 | Twardowski et al. | Oct 1999 | A |
5964796 | Imran | Oct 1999 | A |
5976103 | Martin | Nov 1999 | A |
5976120 | Chow et al. | Nov 1999 | A |
5980551 | Summers et al. | Nov 1999 | A |
5984908 | Davis et al. | Nov 1999 | A |
5989206 | Prosl et al. | Nov 1999 | A |
5989213 | Maginot | Nov 1999 | A |
6001079 | Pourchez | Dec 1999 | A |
6033382 | Basta | Mar 2000 | A |
6036654 | Quinn et al. | Mar 2000 | A |
6059771 | Balbierz et al. | May 2000 | A |
6074374 | Fulton | Jun 2000 | A |
6086555 | Eliasen et al. | Jul 2000 | A |
6090096 | St. Goar et al. | Jul 2000 | A |
6099513 | Spehalski | Aug 2000 | A |
6103778 | Hyon et al. | Aug 2000 | A |
6106540 | White et al. | Aug 2000 | A |
6113572 | Gailey et al. | Sep 2000 | A |
6117117 | Mauch | Sep 2000 | A |
6120494 | Jonkman | Sep 2000 | A |
6126631 | Loggie | Oct 2000 | A |
6146354 | Beil | Nov 2000 | A |
6146373 | Cragg et al. | Nov 2000 | A |
6152909 | Bagaoisan et al. | Nov 2000 | A |
6156016 | Maginot | Dec 2000 | A |
6161547 | Barbut | Dec 2000 | A |
6178356 | Chastain et al. | Jan 2001 | B1 |
6180059 | Divino, Jr. et al. | Jan 2001 | B1 |
6190349 | Ash et al. | Feb 2001 | B1 |
6190371 | Maginot et al. | Feb 2001 | B1 |
6193685 | Goodin | Feb 2001 | B1 |
6196996 | Teirstein | Mar 2001 | B1 |
6206849 | Martin et al. | Mar 2001 | B1 |
6210365 | Afzal | Apr 2001 | B1 |
6210380 | Mauch | Apr 2001 | B1 |
6217527 | Selmon et al. | Apr 2001 | B1 |
6224622 | Kotzev | May 2001 | B1 |
6238406 | Ellis et al. | May 2001 | B1 |
6264627 | Liska et al. | Jul 2001 | B1 |
6273879 | Keith et al. | Aug 2001 | B1 |
6280423 | Davey et al. | Aug 2001 | B1 |
6287326 | Pecor | Sep 2001 | B1 |
6293927 | McGuckin, Jr. | Sep 2001 | B1 |
6293958 | Berry et al. | Sep 2001 | B1 |
6296631 | Chow | Oct 2001 | B2 |
6299631 | Shalaby | Oct 2001 | B1 |
6322551 | Brugger | Nov 2001 | B1 |
6328730 | Harkrider, Jr. | Dec 2001 | B1 |
6342120 | Basta | Jan 2002 | B1 |
6361529 | Goodin et al. | Mar 2002 | B1 |
6383172 | Barbut | May 2002 | B1 |
6394141 | Wages et al. | May 2002 | B2 |
6394142 | Woelfel et al. | May 2002 | B1 |
6409700 | Siegel, Jr. et al. | Jun 2002 | B1 |
6413228 | Hung et al. | Jul 2002 | B1 |
6428513 | Abrahamson | Aug 2002 | B1 |
6443922 | Roberts et al. | Sep 2002 | B1 |
6450988 | Bradshaw | Sep 2002 | B1 |
6453185 | O'Keefe | Sep 2002 | B1 |
6454997 | Divino, Jr. et al. | Sep 2002 | B1 |
6463335 | Munch et al. | Oct 2002 | B1 |
6475207 | Maginot et al. | Nov 2002 | B1 |
6475209 | Larson et al. | Nov 2002 | B1 |
6478789 | Spehalski et al. | Nov 2002 | B1 |
6482169 | Kuhle | Nov 2002 | B1 |
6533763 | Schneiter | Mar 2003 | B1 |
6565594 | Herweck et al. | May 2003 | B1 |
6576001 | Werneth et al. | Jun 2003 | B2 |
6582459 | Lau et al. | Jun 2003 | B1 |
6585705 | Maginot et al. | Jul 2003 | B1 |
6592565 | Twardowski | Jul 2003 | B2 |
6595966 | Davey et al. | Jul 2003 | B2 |
6620118 | Prosl et al. | Sep 2003 | B1 |
6638242 | Wilson et al. | Oct 2003 | B2 |
6659134 | Navis | Dec 2003 | B2 |
6682498 | Ross | Jan 2004 | B2 |
6682519 | Schon | Jan 2004 | B1 |
6695832 | Schon et al. | Feb 2004 | B2 |
6702776 | Quinn | Mar 2004 | B2 |
6712797 | Southern, Jr. | Mar 2004 | B1 |
6712798 | Constantz | Mar 2004 | B2 |
6719717 | Johnson et al. | Apr 2004 | B1 |
6719749 | Schweikert et al. | Apr 2004 | B1 |
6723084 | Maginot et al. | Apr 2004 | B1 |
6723114 | Shalaby | Apr 2004 | B2 |
6730299 | Tayot et al. | May 2004 | B1 |
6752827 | Ross et al. | Jun 2004 | B2 |
6755851 | Noda et al. | Jun 2004 | B2 |
6758836 | Zawacki | Jul 2004 | B2 |
6786664 | Claramunt et al. | Sep 2004 | B2 |
6786884 | DeCant, Jr. et al. | Sep 2004 | B1 |
6796991 | Nardeo | Sep 2004 | B2 |
6797107 | Kotzey | Sep 2004 | B1 |
6808510 | DiFiore | Oct 2004 | B1 |
6814718 | McGuckin, Jr. et al. | Nov 2004 | B2 |
6819951 | Patel et al. | Nov 2004 | B2 |
6821287 | Jang | Nov 2004 | B1 |
6824554 | Jang | Nov 2004 | B1 |
6835452 | Hamerski | Dec 2004 | B1 |
6837864 | Bertolero et al. | Jan 2005 | B1 |
6852079 | Miyano | Feb 2005 | B2 |
6852097 | Fulton, III | Feb 2005 | B1 |
6858019 | McGuckin, Jr. et al. | Feb 2005 | B2 |
6872198 | Wilson et al. | Mar 2005 | B1 |
6878143 | Andersen | Apr 2005 | B2 |
6881211 | Schweikert et al. | Apr 2005 | B2 |
6911014 | Wentling et al. | Jun 2005 | B2 |
6913601 | St. Goar et al. | Jul 2005 | B2 |
6916313 | Cunningham | Jul 2005 | B2 |
6921396 | Wilson et al. | Jul 2005 | B1 |
6921411 | Yock | Jul 2005 | B2 |
6934142 | Grosse et al. | Aug 2005 | B2 |
6966886 | Appling | Nov 2005 | B2 |
6969381 | Voorhees | Nov 2005 | B2 |
6991625 | Gately et al. | Jan 2006 | B1 |
D515211 | Chesnin | Feb 2006 | S |
6997894 | Caresio | Feb 2006 | B2 |
7008395 | Loggie | Mar 2006 | B1 |
7011645 | McGuckin, Jr. et al. | Mar 2006 | B2 |
7018384 | Skakoon | Mar 2006 | B2 |
7029467 | Currier et al. | Apr 2006 | B2 |
7066914 | Andersen | Jun 2006 | B2 |
7066925 | Gately et al. | Jun 2006 | B2 |
7074213 | McGuckin, Jr. et al. | Jul 2006 | B2 |
7077829 | McGuckin, Jr. et al. | Jul 2006 | B2 |
7087053 | Vanney | Aug 2006 | B2 |
7090654 | Lotito et al. | Aug 2006 | B2 |
7108674 | Quinn | Sep 2006 | B2 |
D530420 | Chesnin | Oct 2006 | S |
7128734 | Wilson et al. | Oct 2006 | B1 |
7130700 | Gardeski et al. | Oct 2006 | B2 |
7141035 | Haggstrom | Nov 2006 | B2 |
RE39451 | Kuhle | Dec 2006 | E |
7182746 | Haarala et al. | Feb 2007 | B2 |
7300430 | Wilson et al. | Nov 2007 | B2 |
7322953 | Redinger | Jan 2008 | B2 |
7347852 | Hobbs et al. | Mar 2008 | B2 |
7381204 | Wilson et al. | Jun 2008 | B2 |
7393339 | Zawacki et al. | Jul 2008 | B2 |
7422571 | Schweikert et al. | Sep 2008 | B2 |
7465286 | Patterson et al. | Dec 2008 | B2 |
7485107 | DiFiore et al. | Feb 2009 | B2 |
7569029 | Clark | Aug 2009 | B2 |
7575563 | Appling | Aug 2009 | B2 |
7798999 | Bailey et al. | Sep 2010 | B2 |
8021321 | Zawacki | Sep 2011 | B2 |
8066660 | Gregersen et al. | Nov 2011 | B2 |
8092415 | Moehle | Jan 2012 | B2 |
8152951 | Zawacki et al. | Apr 2012 | B2 |
8206371 | Nimkar et al. | Jun 2012 | B2 |
8292841 | Gregersen | Oct 2012 | B2 |
20010041857 | Sansoucy | Nov 2001 | A1 |
20010041873 | Dopper et al. | Nov 2001 | A1 |
20020013569 | Sterman et al. | Jan 2002 | A1 |
20020026156 | Quinn | Feb 2002 | A1 |
20020086047 | Mueller et al. | Jul 2002 | A1 |
20020087108 | Maginot et al. | Jul 2002 | A1 |
20020087145 | Ehwald et al. | Jul 2002 | A1 |
20020091362 | Maginot et al. | Jul 2002 | A1 |
20020091430 | Dobak et al. | Jul 2002 | A1 |
20020099326 | Wilson et al. | Jul 2002 | A1 |
20020099327 | Wilson et al. | Jul 2002 | A1 |
20020107506 | McGuckin et al. | Aug 2002 | A1 |
20020138031 | Ross | Sep 2002 | A1 |
20020169490 | Noda et al. | Nov 2002 | A1 |
20020177904 | Huxel et al. | Nov 2002 | A1 |
20030023198 | Twardowski | Jan 2003 | A1 |
20030088213 | Schweikert et al. | May 2003 | A1 |
20030093027 | McGuckin et al. | May 2003 | A1 |
20030097091 | Hobbs et al. | May 2003 | A1 |
20030144623 | Heath et al. | Jul 2003 | A1 |
20030149395 | Zawacki | Aug 2003 | A1 |
20030153898 | Schon et al. | Aug 2003 | A1 |
20030187411 | Constantz | Oct 2003 | A1 |
20030204179 | Davey et al. | Oct 2003 | A1 |
20040054321 | Schon et al. | Mar 2004 | A1 |
20040059314 | Schon et al. | Mar 2004 | A1 |
20040064086 | Gottlieb et al. | Apr 2004 | A1 |
20040065333 | Wilson et al. | Apr 2004 | A1 |
20040075198 | Schweikert et al. | Apr 2004 | A1 |
20040087892 | Cunningham | May 2004 | A1 |
20040092863 | Raulerson et al. | May 2004 | A1 |
20040097863 | Appling | May 2004 | A1 |
20040097903 | Raulerson | May 2004 | A1 |
20040122418 | Voorhees | Jun 2004 | A1 |
20040147903 | Latini | Jul 2004 | A1 |
20040167463 | Zawacki et al. | Aug 2004 | A1 |
20040171997 | Wilson et al. | Sep 2004 | A1 |
20040172003 | Wilson et al. | Sep 2004 | A1 |
20040176739 | Stephens et al. | Sep 2004 | A1 |
20040193102 | Haggstrom | Sep 2004 | A1 |
20040210180 | Altman | Oct 2004 | A1 |
20040210187 | Zawacki | Oct 2004 | A1 |
20040210237 | Ross et al. | Oct 2004 | A1 |
20040220550 | Schryver | Nov 2004 | A1 |
20040230204 | Wortley et al. | Nov 2004 | A1 |
20040243095 | Nimkar et al. | Dec 2004 | A1 |
20040249337 | DiFiore | Dec 2004 | A1 |
20050003322 | Logan et al. | Jan 2005 | A1 |
20050004504 | Frye et al. | Jan 2005 | A1 |
20050013341 | Baghai | Jan 2005 | A1 |
20050025641 | Shibata et al. | Feb 2005 | A1 |
20050027282 | Schweikert et al. | Feb 2005 | A1 |
20050027289 | Castellano et al. | Feb 2005 | A1 |
20050033222 | Haggstrom et al. | Feb 2005 | A1 |
20050054989 | McGuckin et al. | Mar 2005 | A1 |
20050055012 | Trerotola | Mar 2005 | A1 |
20050059925 | Maginot et al. | Mar 2005 | A1 |
20050070842 | Lotito et al. | Mar 2005 | A1 |
20050080398 | Markel et al. | Apr 2005 | A1 |
20050085765 | Voorhees | Apr 2005 | A1 |
20050096585 | Schon et al. | May 2005 | A1 |
20050113904 | Shank et al. | May 2005 | A1 |
20050131341 | McGuckin et al. | Jun 2005 | A1 |
20050171469 | Cunningham | Aug 2005 | A1 |
20050187535 | Wilson et al. | Aug 2005 | A1 |
20050228339 | Clark | Oct 2005 | A1 |
20050245900 | Ash | Nov 2005 | A1 |
20050256461 | DiFiore et al. | Nov 2005 | A1 |
20050261663 | Patterson et al. | Nov 2005 | A1 |
20050267400 | Haarala et al. | Dec 2005 | A1 |
20050277862 | Anand | Dec 2005 | A1 |
20050288623 | Hjalmarsson | Dec 2005 | A1 |
20050288706 | Widomski et al. | Dec 2005 | A1 |
20060004316 | Difiore et al. | Jan 2006 | A1 |
20060004325 | Hamatake et al. | Jan 2006 | A1 |
20060009783 | Rome et al. | Jan 2006 | A1 |
20060015072 | Raulerson | Jan 2006 | A1 |
20060015130 | Voorhees et al. | Jan 2006 | A1 |
20060030827 | Raulerson et al. | Feb 2006 | A1 |
20060047267 | Gately et al. | Mar 2006 | A1 |
20060047268 | Stephens | Mar 2006 | A1 |
20060058775 | Stevens et al. | Mar 2006 | A1 |
20060064072 | Gately et al. | Mar 2006 | A1 |
20060095062 | Stephens | May 2006 | A1 |
20060100572 | DiMatteo et al. | May 2006 | A1 |
20060161100 | Hamboly | Jul 2006 | A1 |
20060184142 | Schon et al. | Aug 2006 | A1 |
20060189922 | Amarasinghe et al. | Aug 2006 | A1 |
20060206094 | Chesnin et al. | Sep 2006 | A1 |
20060251612 | Kotzev et al. | Nov 2006 | A1 |
20060253063 | Schweikert | Nov 2006 | A1 |
20060271012 | Canaud et al. | Nov 2006 | A1 |
20070005003 | Patterson et al. | Jan 2007 | A1 |
20070066964 | Atkins | Mar 2007 | A1 |
20070078478 | Atkins et al. | Apr 2007 | A1 |
20070106206 | Appling | May 2007 | A1 |
20070129704 | O'Mahony et al. | Jun 2007 | A1 |
20070167925 | Jacqmein | Jul 2007 | A1 |
20070225661 | Ash et al. | Sep 2007 | A1 |
20070225682 | Ash et al. | Sep 2007 | A1 |
20070282274 | Chesnin | Dec 2007 | A1 |
20080021417 | Zawacki et al. | Jan 2008 | A1 |
20080039774 | Zawacki et al. | Feb 2008 | A1 |
20080082079 | Braga et al. | Apr 2008 | A1 |
20080082080 | Braga | Apr 2008 | A1 |
20080097409 | Stephens | Apr 2008 | A1 |
20080214980 | Anand | Sep 2008 | A1 |
20080214992 | Haarala et al. | Sep 2008 | A1 |
20090112153 | Gregersen et al. | Apr 2009 | A1 |
20090118661 | Moehle et al. | May 2009 | A1 |
20090118701 | Nimkar et al. | May 2009 | A1 |
20090118707 | Schweikert et al. | May 2009 | A1 |
20090192435 | Gregersen | Jul 2009 | A1 |
20090204079 | Nimkar et al. | Aug 2009 | A1 |
20090205189 | Nimkar et al. | Aug 2009 | A1 |
20090209940 | Nimkar et al. | Aug 2009 | A1 |
20100331780 | Bellisario et al. | Dec 2010 | A1 |
20110020418 | Bosley, Jr. et al. | Jan 2011 | A1 |
20120059304 | Gregersen et al. | Mar 2012 | A1 |
20120089070 | Moehle et al. | Apr 2012 | A1 |
20120203206 | Nimkar et al. | Aug 2012 | A1 |
Number | Date | Country |
---|---|---|
834211 | Feb 1976 | BE |
1150122 | Jul 1983 | CA |
2474351 | Aug 2003 | CA |
2788836 | Jun 2006 | CN |
8815869 | Mar 1989 | DE |
9108132 | Jun 1991 | DE |
102005051211 | May 2007 | DE |
0030854 | Jun 1981 | EP |
0132344 | Jan 1985 | EP |
0301854 | Feb 1989 | EP |
0332366 | Sep 1989 | EP |
0386408 | Sep 1990 | EP |
0453234 | Oct 1991 | EP |
0476796 | Mar 1992 | EP |
0495263 | Jul 1992 | EP |
0 650 740 | May 1995 | EP |
0711574 | May 1996 | EP |
1471966 | Nov 2004 | EP |
1599247 | Nov 2005 | EP |
1503469 | Mar 1978 | GB |
56-136569 | Oct 1981 | JP |
8-510935 | Nov 1996 | JP |
201137350 | May 2001 | JP |
2008500081 | Jan 2008 | JP |
4827377 | Nov 2011 | JP |
249060 | Sep 2007 | MX |
459237 | Feb 1975 | SU |
45923 | Nov 2004 | SU |
9108132 | Jun 1991 | WO |
WO-9316741 | Sep 1993 | WO |
WO-9316752 | Sep 1993 | WO |
9709086 | Mar 1997 | WO |
9717102 | May 1997 | WO |
WO-9722374 | Jun 1997 | WO |
9737699 | Oct 1997 | WO |
9904844 | Feb 1999 | WO |
0023137 | Apr 2000 | WO |
02058776 | Aug 2002 | WO |
02083223 | Oct 2002 | WO |
03030960 | Apr 2003 | WO |
03033049 | Apr 2003 | WO |
03066148 | Aug 2003 | WO |
2004075962 | Sep 2004 | WO |
2004096334 | Nov 2004 | WO |
2004112876 | Dec 2004 | WO |
WO-2005018712 | Mar 2005 | WO |
WO-2005023336 | Mar 2005 | WO |
2005077449 | Aug 2005 | WO |
2005084741 | Sep 2005 | WO |
2005118039 | Dec 2005 | WO |
2006034877 | Apr 2006 | WO |
2009051967 | Apr 2009 | WO |
2009055332 | Apr 2009 | WO |
Entry |
---|
OriGen, “OriGen Biomedical Dual Lumen Catheter,” http://origen.net/catheter.html, Copyright 2005, 4 pages. |
International Search Report & Written Opinion, PCT/US2008/078551, Issued Mar. 13, 2009, 12 pages. |
International Search Report & Written Opinion, PCT/US2008/078560, Issued Mar. 16, 2009, 11 pages. |
International Search Report & Written Opinion, PCT/US2008/078566, Issued Mar. 19, 2009, 11 pages. |
International Search Report & Written Opinion, PCT/US2008/078571 Issued Mar. 16, 2009, 12 pages. |
U.S. Appl. No. 12/244,544, filed Oct. 2, 2008, Fusion Manufacture of Multi-Lumen Catheters. |
U.S. Appl. No. 12/244,554, filed Oct. 2, 2008, Catheters with Enlarged Arterial Lumens. |
U.S. Appl. No. 12/244,559, filed Oct. 2, 2008, Manufacture of Fixed Tip Catheters. |
Arrow Cannon II Plus brochure (2006). |
Bander, et al., Central Venous Angioaccess for Hemodialysis and Its Complications, Seminars in Dialysis, 1992, vol. 5, No. 2, pp. 121-128. |
Baranowski, L., Central Venous Access Devises, Journal of Intravenous Nursing, 1993, vol. 16, No. 3, pp. 167-194. |
Believed to be an unpublished sketch of a conception by Dr. John Frusha; date of sketch believed to be Jun. 24, 1997. |
Berkoben, et al., Maintenance of Permanent Hemodialysis Vascular Access Patency, ANNA Journal, 1995, vol. 22, No. 1, pp. 17-24. |
Bolz, et al., Catheter Malfunction and Thrombus Formation on Double-Lumen Hemodialysis Catheters: An Intravascular Ultrasonographic Study, American Journal of Kidney Diseases, 1995, vol. 25, No. 4, pp. 597-602. |
Bour, et al., Experience With the Double Lumen Silastic® Catheter for Hemoaccess Surgery, Gynecology & Obstetrics, 1990, vol. 171, pp. 33-39. |
Campbell, et al., Radiological Insertion of Long-term Venous Access Devises, Seminars in Interventional Radiology, 1994, vol. 11, No. 4. pp. 366-375. |
Canaud, B. et al., “Permanent Twin Catheter: a Vascular Access Option of Choice for Haemodialysis in Elderly Patients,” 13(7):82-88 (1998). |
Claim Construction Order of Federal District Court dated May 9, 2005 in Thierry Pourchez and Bard Access Systems, Inc. v. Diatek, Inc. and Arrow International, Inc. litigation (S.D. N.Y. 03 Civ. 0972). |
Claim Construction Order of Federal District Court dated Oct. 31, 2006 in Arrow Int'l. Inc. and Arrow Int'l. Investment Corp. v. Spire Biomedical, Inc. litigation, (D. Mass. Civil Action No. 06-CV-11564). |
Decision of Federal District Court dated Jul. 7, 2009 granting Summary Judgment of Invalidity in Arrow Int'l. Inc. and Arrow Int'l. Investment Corp. v. Spire Biomedical, Inc. litigation, (D. Mass. Civil Action No. 06-CV-11564). |
Dialysis Vascular Access, Technological Innovations Improving Flow(AngioDynamics Inc.) brochure, 4 pages. |
Donaldson, et al., Peripherally Inserted Central Venous Catheters: US-guided Vascular Access in Pediatric Patients1, Radiology, 1995, vol. 197, pp. 542-544. |
Dunea, et al., A Survey of Permanent Double Lumen Catheters in Hemodialysis Patients, ASAIO Transac. 1991:37:M276-7. |
Dupont et al., “Long-Term Development of Permcath Quinton Catheter” [French] Néphrologie 15: 105-10 (1994). |
Gallichio, et al., Placement of a Double Lumen Silastic Catheter for Hemodialysis Access Through the Cephalic Vein, Journal of the American College of Surgeons, 1994, vol. 179, pp. 171-172. |
Gravenstein, et al., In Vitro Evaluation of Relative Perforating Potential of Central Venous Catheters: Comparison of Materials, Selected Models, Number of Lumens, and Angles of Incidence to Simulated Membrane, Journal of Clinical Monitoring, 1991, vol. 7, pp. 1-6. |
Haindl, H., Technical complications for port-catheter systems, Reg. Cancer Treat, 1989, 2:238-242. |
Haire, et at., Thrombotic Complications of Subclavian Apheresis catheters in Cancer Patients: Prevention With Heparin Infusion, Journal of Clinical Apheresis, 1990, vol. 5, pp. 188-191. |
Hull, et al., The Groshong Catheter: Initial Experience and Early Results of Imaging-guided Placement1, Radiology, 1992, vol. 185, pp. 803-807. |
Ignotus, et al., Review of Radiological Insertion of Indwelling Central Venous Catheters, minimally invasive Therapy, 1992, 1:373-388. |
Instructions for Use (Copyright Dated 1990) for Polycath Polyurethance Central Venous Catheter; believed to have been packaged with product believed to have been sold in the United States before Jan. 2000 and related marketing materials. |
Instructions for Use (Copyright Dated 1992) for FloLock Single Lumen Bi-directional Valved Catheter; believed to have been packaged with product believed to have been sold in the United States before Jan. 2000. |
Instructions for Use (not dated) for Infuse-a-Cath Polyurethance Central Venous Catheter; believed to have been packaged with product believed to have been sold in the United States before Jan. 2000. |
Instructions for Use for Diatek Cannon Catheter Product First Sold in the United States Sep. 2001. |
Jones, et al., Efficacy of the Supraclavicular Route for Temporary Hemodialysis Access, Southern Medical Journal, 1992, vol. 85, No. 7, pp. 725-726. |
Kaupke, et al., Perforation of the Superior Vena Cava by a Subclavin Hemodialysis Catheter: early detection by angiography, The International Journal of Artificial Organs, 1992, vol. 15, No. 11, pp. 666-668. |
Kelber, et al., Factors Affecting Delivery of High-Efficiency Dialysis Using Temporary Vascular Access, American Journal of Kidney Diseases, 1993, vol. 22, No. 1, pp. 24-29. |
Lumsden, et al., Hemodialysis Access in the Pediatric Patient Population, The American Journal of Surgery, 1994, vol. 168, pp. 197-201. |
Lund, “Percutaneous Translumber Inferior Vena Cava Cannulation and other Alternative Vascular Access Techniques” in Venous Interventional Radiology with Clinical Perspectives, Savader et al, eds, pp. 251-261 (date unknown). |
Lund, et al., Percutaneous Translumber Inferior Vena Cava Cannulation for Hemodialysis, American Journal of Kidney Diseases, 1995, vol. 25, No. 5, pp. 732-737. |
Maki, D., Pathogenesis, Prevention, and Management of Infections Due to Intravascular Devices Used for Infusion Therapy, in Infections Associated with Indwelling Medical Devices, Bisno et al, eds, American Society for Microbiology, 1989, pp. 161-177. |
Mauro, et al., Radiologic Placement of Long-term Central Venous Catheters: A Review, JVIR, 1993, vol. 4, No. 1, pp. 127-137. |
McGee, et al., Accurate placement of central venous catheters: A prospective, randomized, multicenter trial, Critical Care Medicine, 1993, vol. 21, No. 8, pp. 1118-1123. |
Medcomp, “For Access via the Internal Jugular Vein . . . The Medcomp TESIO Catheter is the Solution: The Short and Long Term Solution to Subclavian Venin Stenosis and Difficult Access Problems”—Brochure, 4 pp. |
Northsea, C., Using Urokinase to Restore Patency in Double Lumen Catheters, ANNA Journal 1994, vol. 21, No. 5, pp. 261-273. |
Parsa, et al., Establishment of Intravenous Lines for Long-term Intravenous Therapy and Monitoring, Surgical Clinics of N. Am. 1985, vol. 65, No. 4, pp. 835-865. |
Parsa, et al., Vascular Access Techniques, Monitoring, pp. 122-145 (date unknown). |
Pasquale, et al., Groshong® versus Hickman® Catheters, Surgery, Gynecology & Obstetrics, 1992, vol. 174, pp. 408-410. |
Passaro, et al., Long-term Silastic Catheters and Chest Pain, Journal of Parenteral andEnteral Nutrition, 1994, vol. 18, Bo. 3, pp. 240-242. |
Paulsen, et al., Use of Tissue Plasminogen Activator for Reopening of Clotted Dialysis Catheters, Nephron, 1993, vol. 64, pp. 468-470. |
Picture of device believed to be partial sample of a product believed to have been sold in the United States with the Polycath and/or Infuse-a-Cath Instructions for Use, 1 page. |
Quinton® Catheter Products (1993). |
Raaf, et al., Open Insertion of Right Atrial Catheters Through the Jugular Veins, surgery, Gynecology & Obstetrics, 1993, vol. 177, pp. 295-298. |
Schwab, et al., Prospective Evaluation of a Dacron Cuffed Hemodialysis Catheter for Prolonged Use, American Journal of Kidney Diseases, 1998, vol. XI, No. 2, pp. 166-169. |
Schwab, et al., Vascular Access: Case Oriented Discussions of Selected Critical Issues: Hemodialysis Catheters for Permanent Use (date unknown). |
Shaffer D., lessons from Vascular Access Procedures for Hemodialysis, Surgical Oncology Clinics of North America, 1995, vol. 4, No. 3, pp. 537-549. |
Shaffer, D., Catheter-Related Sepsis Complication Long-Term Tunnelled Central Venous Dialysis Catheters: Management by Guidewire Exchange, American Journal of Kidney Disease, 1995, vol. 25, No. 4. pp. 593-596. |
Sioshansi, P., New Processes for Surface Treatment of Catheters, Artificial Organs, 1994, 18(4):266-271. |
Swartz, et al., Successful Use of Cuffed Central venous Hemodialysis Catheters Inserted Percutaneously, J. Am. Soc. Nephrol., 1994, 4:1719-1725. |
Tesio, et al., Double Catherization of the Internal Jugular Vein for Hemodialysis: Indications, Techniques, and Clinical Results, Artificial Organs, 1994, vol. 18, No. 4, pp. 301-304. |
Treiman, et al., Chronic Venous Access in Patients with Cancer, Cancer, 1993, vol. 72, No. 3, pp. 760-765. |
Twadorski, et al., “Blood Recirculation in Intravenous Catheters for Hemodialysis” J. am. Soc. Nephrol. 3:1978-81 (1993). |
Uldall, P. Subclavian Cannulation Is No longer Necessary or justified in Patients with End-Stage Renal failure, Seminar in Dialysis, 1994, vol. 7, No. 3, pp. 161-164. |
Wechsler, et al., Thrombosis and Infection Caused by Thoracic Venous Catheters: Pathogenesis and Imagings Findings, AJR, 1993; 160:467-471. |
Weitzel, et al., Successful use if Indwelling Cuffed Femoral Vein Catheters in Ambulatory Hemodialysis Patients, America Journal of Kidney diseases, 1993, vol. 22, No. 3, pp. 426-429. |
PCT/US2008/082106 filed Oct. 31, 2008 Written Opinion dated Jan. 12, 2009. |
Raaf Dual Lumen Right Atrial Catheters Brochure—Quinton Instrument Co., 6 pages, 1993. |
Rawn, et al., The Hemodialysis Access, Chapter 9, pp. 9.1-9.11. |
Tal, Michael G. Comparison of Recirculation Percentage of the Palindrome Catheter and Standard Hemodialysis Catheters in a Swine Model, J Vasc Interv Radiol, pp. 1237-1240, vol. 16, No. 9, 2005. |
The Groshong™ Peripherally Inserted Central Venous Catheter Brochure—Cath-tech®, 4 pages, 1988. |
Transcript of Videotaped Deposition of Gregory Haas (Excerpt), Sep. 23, 2003, Thierry Pourchez and Bard Access Systems, Inc. v. Diatek, Inc. and Arrow International, Inc., Civil Action No. 03-CV-0972 (S.D.N.Y). |
Transcript of Videotaped Deposition of Thierry Pourchez, vol. 1, Oct. 16, 2003, Thierry Pourchez and Bard Access Systems, Inc. v. Diatek, Inc. and Arrow International, Inc., Civil Action No. 03-CV-0972 (S.D.N.Y). |
Transcript of Videotaped Deposition of Thierry Pourchez, vol. 2, Oct. 17, 2003, Thierry Pourchez and Bard Access Systems, Inc. v. Diatek, Inc. and Arrow International, Inc., Civil Action No. 03-CV-0972 (S.D.n. Y). |
Twardowski et al. “Side Holes at the Tip of Chronic Hemodialysis Catehters are Harmful,” The Journal of Vascular Access 2001; 2:8-16. |
Twardowski, et al., Side Holes at the Tip of Chronic Hemodialysis Catheters are Harmful, The Journal of Vascular Access 2001; 2: 8 16. |
TYCO Healthcare, MAHURKAR Dual Lumen Catheters, Informational Brochure, 2 pages, 2004. |
TYCO Healthcare, MAHURKAR QPlus High Flow Acute Care Catheter, Informational Brochure, 2 pages, 2004. |
TYCO Healthcare, Tal PALINDROME™ Dual Lumen Catheters Order Information, Features and Benefits, Frequently Asked Questions, printed from http://www.kendallvasculartherapy.com/VascularTherapy, 6 pages, on Mar. 1, 2007. |
U.S. Appl. No. 10/445,731, filed May 27, 2003 Non-Final Office Action dated Apr. 13, 2007. |
U.S. Appl. No. 10/445,731, filed May 27, 2003 Non-Final Office Action dated Dec. 12, 2008. |
U.S. Appl. No. 10/445,731, filed May 27, 2003 Non-Final Office Action dated May 30, 2008. |
U.S. Appl. No. 10/874,298, filed Jun. 9, 2004 Advisory Action dated Feb. 19, 2009. |
U.S. Appl. No. 10/874,298, filed Jun. 9, 2004 Final Office Action dated Jul. 15, 2008. |
U.S. Appl. No. 10/874,298, filed Jun. 9, 2004 Final Office Action dated Jul. 7, 2010. |
U.S. Appl. No. 10/874,298, filed Jun. 9, 2004 Non-Final Office Action dated Aug. 18, 2011. |
U.S. Appl. No. 10/874,298, filed Jun. 9, 2004 Non-Final Office Action dated Dec. 30, 2009. |
U.S. Appl. No. 10/874,298, filed Jun. 9, 2004 Non-Final Office Action dated Feb. 2, 2011. |
U.S. Appl. No. 10/874,298, filed Jun. 9, 2004 Non-Final Office Action dated Jul. 23, 2009. |
U.S. Appl. No. 10/874,298, filed Jun. 9, 2004 Non-Final Office Action dated May 23, 2006. |
U.S. Appl. No. 10/874,298, filed Jun. 9, 2004 Non-Final Office Action dated May 24, 2007. |
U.S. Appl. No. 11/859,106, filed Sep. 21, 2007 Final Office Action dated Sep. 1, 2009. |
U.S. Appl. No. 11/859,106, filed Sep. 21, 2007 Non-Final Office Action dated Mar. 30, 2011. |
U.S. Appl. No. 11/859,106, filed Sep. 21, 2007 Non-Final Office Action dated Jun. 25, 2008. |
U.S. Appl. No. 12/048,871, filed Mar. 14, 2008 Final Office Action dated Jan. 20, 2011. |
U.S. Appl. No. 12/048,871, filed Mar. 14, 2008 Non-Final Office Action dated Jan. 7, 2010. |
U.S. Appl. No. 12/048,871, filed Mar. 14, 2008 Non-Final Office Action dated Jul. 7, 2010. |
U.S. Appl. No. 12/048,871, filed Mar. 14, 2008 Non-Final Office Action dated May 12, 2009. |
U.S. Appl. No. 12/244,544, filed Oct. 2, 2008 Final Office Action dated Jul. 11, 2011. |
U.S. Appl. No. 12/244,544, filed Oct. 2, 2008 Non-Final Office Action dated Dec. 22, 2010. |
U.S. Appl. No. 12/244,554, filed Oct. 2, 2008 Final Office Action dated Dec. 27, 2010. |
U.S. Appl. No. 12/244,554, filed Oct. 2, 2008 Non-Final Office Action dated Jul. 6, 2010. |
U.S. Appl. No. 12/253,870, filed Oct. 17, 2008 Non-Final Office Action dated Jan. 21, 2011. |
U.S. Appl. No. 12/253,870, filed Oct. 17, 2008 Notice of Allowance dated Aug. 19, 2011. |
U.S. Appl. No. 12/262,820, filed Oct. 31, 2008 Non-Final Office Action dated Feb. 18, 2011. |
U.S. Appl. No. 12/263,141, filed Oct. 31, 2008 Advisory Action dated Aug. 17, 2011. |
U.S. Appl. No. 12/263,141, filed Oct. 31, 2008 Final Office Action dated May 26, 2011. |
U.S. Appl. No. 12/263,141, filed Oct. 31, 2008 Non-Final Office Action dated Jan. 5, 2011. |
U.S. Appl. No. 12/414,467, filed Mar. 30, 2009 Non-Final Office Action dated Aug. 11, 2011. |
U.S. Appl. No. 10/842,586, filed May 10, 2004 Advisory Action dated Oct. 9, 2008. |
U.S. Appl. No. 10/842,586, filed May 10, 2004 Final Office Action dated May 25, 2010. |
U.S. Appl. No. 10/842,586, filed May 10, 2004 Final Office Action dated Jul. 29, 2008. |
U.S. Appl. No. 10/842,586, filed May 10, 2004 Non-Final Office Action dated Jan. 7, 2008. |
U.S. Appl. No. 10/842,586, filed May 10, 2004 Non-Final Office Action dated Jun. 16, 2009. |
U.S. Appl. No. 10/842,586, filed May 10, 2004 Non-Final Office Action dated Nov. 13, 2008. |
U.S. Appl. No. 10/842,586, filed May 10, 2004 Non-Final Office Action dated Nov. 23, 2009. |
Arrow International, Inc. et al v. Spire Biomedical, Inc., U.S. Dist Ct Dist MA CA No. 06-CV-11564-DPW, Declaration of Dr. Karim Valji (Jul. 17, 2008). |
Arrow International, Inc. et al v. Spire Biomedical, Inc., U.S. Dist Ct Dist MA CA No. 06-CV-11564-DPW, Declaration of Kenneth Todd Cassidy (Jul. 16, 2008). |
Arrow International, Inc. et al v. Spire Biomedical, Inc., U.S. Dist Ct Dist MA CA No. 06-CV-11564-DPW, Declaration of Rebecca R. Eisenberg in Opposition to Defendant's Motion for Partial Summary Judgment of Invalidity (Jun. 8, 2009). |
Arrow International, Inc. et al v. Spire Biomedical, Inc., U.S. Dist Ct Dist MA CA No. 06-CV-11564-DPW, Memorandum of Law in Support of Defendant's Motion for Summary Judgment on Invalidity [Redacted Pursuant to Jun. 10, 2008 Order on Motion to Seal]. |
Arrow International, Inc. et al v. Spire Biomedical, Inc., U.S. Dist Ct Dist MA CA No. 06-CV-11564-DPW, Memorandum of Law in Support of Defendant's Motion for Summary Judgment on Invalidity Exhibit A (Jul. 10, 2009). |
Arrow International, Inc. et al v. Spire Biomedical, Inc., U.S. Dist Ct Dist MA CA No. 06-CV-11564-DPW, Plaintiff's Memorandum in Opposition to Defendant's Motion for Summary Judgement on Non-Infringement (Jul. 17, 2008). |
Arrow International, Inc. et al. v. Spire Biomedical, Inc., U.S. Dist. Ct. Dist. MA CA No. 06-CV-11564-DPW, Defendant's Omnibus Statement of Material Facts in Support of its Motions for Summary Judgment [Redacted Pursuant to Jun. 10, 2007 Order on Motion to Seal]. |
BARD Access Systems Hickman®, Leonard®, and Broviac® Central Venous Catheters (Long Term), Instructions for Use, 31 pages, 1999. |
BARD Access Systems Hickman®, Leonard®, and Broviac® Central Venous Catheters, Nursing Procedural Manual, 52 pages, Jun. 1994. |
BARD Davol® Hickman® Round Dual Lumen Catheters for Central Venous Access Informational Brochure, 2 pages, 1994. |
BARD Hickman® Catheters Informational Brochure, 3 pages, 1994. |
CAMP, “Care of the Groshong Catheter”, Oncol Nurs Forum, vol. 15, No. 6, 1988. |
Declaration of Gregory S. Haas (Plaintiff's Exhibit 88 in Haas Deposition), Mar. 13, 2003, Thierry Pourchez and Bard Access Systems, Inc. v. Diatek, Inc. and Arrow International, Inc., Civil Action No. 03-CV-0972 (S.D.N.Y.). |
Defendant's Exhibits DX78-DX114, Thierry Pourchez and Bard Access Systems, Inc. v. Diatek, Inc. and Arrow International, Inc., Civil Action No. 03-CV-0972 (S.D.N.Y.). |
Defendants' Reponses and Objections to Plaintiffs' Second Set of Interrogatories (Excerpt), Thierry Pourchez and Bard Access Systems, Inc. v. Diatek, Inc. and Arrow International, Inc., Civil Action No. 03-CV-0972 (S.D.N.Y.) (Oct. 8, 2003). |
Delmore et al., “Experience with the Groshong Long-Term Central Venous Catheter”, Gynecologic Oncology 34, 216-218 (1989). |
Dialysis Vascular Access, SchonXL® Temporary Dialysis (AngioDynamics Inc.) brochure. |
Difiore, “Central Venous Dialysis Catheter Evaluatio in Swine”, Journal of Vascular Access Devices, Fall 2000. |
Dupont et al, Long-term development of Permacath Quinton catheters used as a vascular access route for extra-renal detoxification; Néphrologie, vol. 15, pp. 105-110, 1994. |
EP 04712925.9 filed Feb. 19, 2004 Office Action dated Nov. 7, 2008. |
EP 08839196.6 filed Oct. 2, 2008 Search Opinion dated Jul. 12, 2011. |
EP 08839196.6 filed Oct. 2, 2008 Search Report dated Jul. 12, 2011. |
JP App. No. 2003-565569 filed Feb. 7, 2003, Translated Decision of Refusal mailed Dec. 24, 2009. |
JP App. No. 2003-565569 filed Feb. 7, 2003, Translated Official Action mailed May 28, 2009. |
JP App. No. 2003-565569 filed Feb. 7, 2003, Translated Official Action mailed Nov. 7, 2008. |
Kapoian et al. Dialysis as Treatment of End-Stage Renal Disease, Chapter 5: Dialysis Access and Recirculation. |
Malviya et al., “Vascular Access in Gynecological Cancer Using the Groshong Right Atrial Catheter”, Gynecological Oncology 33, 313-316 (1989). |
Medcomp® Brochure , “Ash Split Cath™ XL”, Dec. 2001, PN 2291. |
Medcomp® Brochure , “Ash Split Cath™”, Guidewire Weave Insertion Technique, Jan. 2002, PN 2296. |
Medcomp® Brochure , “Ash Split Cath™”, Jul. 2001, PN 2114. |
Medcomp® Brochure , “Ash Split Cath™”, Nov. 1997, PN 2050. |
Medcomp® Brochure , “Ash Split Cath® II”, Aug. 2002, PN 2334. |
Medcomp® Brochure , “Magna™ High Flow Catheter”, Mar. 2002, PN 2321. |
Moss, et al., Use of a Silicone Catheter With a Dacron Cuff for Dialysis Short-Term Vascular Access, American Journal of Kidney Diseases, 1988, vol. XII, No. 6, pp. 492-498. |
Myers, R.D. et al, New Double-lumen Polyethylene Cannula for Push-pull Perfusion of Brain Tissue in Vivo, Journal of Neuroscience Methods, pp. 205-218, vol. 12, 1985. |
Patel et al., “Sheathless Technique of Ash Split-Cath Insertion”, 12 JVIR 376-78 (Mar. 2001). |
PCT/US2003/003751 filed Feb. 7, 2003 Preliminary Examination Report dated May 5, 2004. |
PCT/US2003/003751 filed Feb. 7, 2003 Search Report dated Jul. 3, 2003. |
PCT/US2004/005102 filed Feb. 19, 2004 Preliminary Report Patenability dated Aug. 29, 2005. |
PCT/US2004/005102 filed Feb. 19, 2004 Search Report dated Dec. 27, 2004. |
PCT/US2008/078551 filed Oct. 2, 2008 International Preliminary Report on Patentability dated Apr. 20, 2010. |
PCT/US2008/078560 filed Oct. 2, 2008 Preliminary Report on Patentability dated Aug. 26, 2010. |
PCT/US2008/078566 filed Oct. 2, 2008 International Preliminary Report on Patentability dated Apr. 20, 2010. |
PCT/US2008/078571 filed Oct. 2, 2008 Preliminary Report on Patentability dated Aug. 26, 2010. |
PCT/US2008/080463 filed Oct. 20, 2008 Preliminary Report on Patentability dated Apr. 27, 2010. |
PCT/US2008/080463 filed Oct. 20, 2008 Search Report dated Mar. 16, 2009. |
PCT/US2008/080463 filed Oct. 20, 2008 Written Opinion dated Apr. 16, 2009. |
PCT/US2008/082106 filed Oct. 31, 2008 International Preliminary Report on Patentability dated May 4, 2010. |
PCT/US2008/082106 filed Oct. 31, 2008 Search Report dated Jan. 12, 2009. |
CN 200880121182.0 filed Oct. 20, 2008 First Office Action dated May 2, 2012. |
CN 200880121183.5 filed Oct. 2, 2008 First Office Action dated Mar. 28, 2012. |
CN 200880121183.5 filed Oct. 2, 2008 Second Office Action dated Aug. 17, 2012. |
CN 200880121183.5 filed Oct. 2, 2008 Third Office Action dated Dec. 11, 2012. |
CN 200880123095.9 filed Oct. 20, 2008 First Office Action dated Feb. 13, 2012. |
CN 200880123095.9 filed Oct. 20, 2008 Second Office Action dated Dec. 18, 2012. |
CN 200880123533.1 filed Jun. 30, 2008 First Office Action dated May 28, 2012. |
CN 200880123533.1 filed Jun. 30, 2008 Notice of Grant dated Dec. 24, 2012. |
EP 08839196.6 filed Oct. 2, 2008 Examination Report dated Jan. 16, 2013. |
EP 08872340.8 filed Oct. 2, 2008 Extended European Search Report and an Opinion dated Apr. 19, 2012. |
JP 2010-532299 filed Apr. 30, 2010 Final Notice of Reason for Rejection dated Feb. 8, 2013. |
JP 2010-532299 filed Apr. 30, 2010 Official Action dated Apr. 23, 2012. X. |
Septum, Wikipedia, The Free Encyclopedia, hhtp://en.wikipedia.org/wiki/Septum (last visited Dec. 18, 2012) (defining “septum” as “A wall, dividing a cavity or structure into smaller ones”). |
Taber's Cyclopedic Medical Dictionary 1662 (16th ed. 1989) (defining “septum” as a “wall dividing two cavities”). |
U.S. Appl. No. 10/371,774, filed Feb. 21, 2003 Final Office Action dated Jan. 19, 2007. |
U.S. Appl. No. 10/371,774, filed Feb. 21, 2003 Final Office Action dated Mar. 7, 2007. |
U.S. Appl. No. 10/371,774, filed Feb. 21, 2003 Non-Final Office Action dated Jul. 17, 2006. |
U.S. Appl. No. 10/371,774, filed Feb. 21, 2003 Notice of Allowance dated Jun. 1, 2007. |
U.S. Appl. No. 11/859,106, filed Aug. 21, 2007 Non-Final Office Action dated Feb. 5, 2009. |
U.S. Appl. No. 11/874,447, filed Oct. 18, 2007 Decision on Appeal dated Dec. 26, 2012. |
U.S. Appl. No. 11/874,447, filed Oct. 18, 2007 Examiner's Answer dated Apr. 28, 2010. |
U.S. Appl. No. 11/874,447, filed Oct. 18, 2007 Final Office Action dated Jul. 22, 2009. |
U.S. Appl. No. 11/874,447, filed Oct. 18, 2007 Non-Final Office Action dated Jan. 6, 2009. |
U.S. Appl. No. 11/874,447, filed Oct. 18, 2007 Non-Final Office Action dated Jul. 9, 2008. |
U.S. Appl. No. 12/048,871, filed Mar. 14, 2008 Examiner's Answer dated Feb. 9, 2012. |
U.S. Appl. No. 12/244,559, filed Oct. 2, 2009 Final Office Action dated Jul. 3, 2012. |
U.S. Appl. No. 12/244,559, filed Oct. 2, 2009 Non-Final Office Action dated Mar. 14, 2012. |
U.S. Appl. No. 12/262,820, filed Oct. 31, 2008 Notice of Allowance dated Sep. 28, 2011. |
U.S. Appl. No. 12/414,467, filed Mar. 30, 2009 Final Office Action dated Feb. 7, 2012. |
U.S. Appl. No. 12/414,467, filed Mar. 30, 2009 Notice of Allowance dated May 31, 2012. |
U.S. Appl. No. 13/445,713, filed Apr. 12, 2012 Non-Final Office Action dated Jan. 2, 2013. |
US Patent File History USPN 5,403,291 (Abrahamson). |
US Patent File History USPN 5,489,278 (Abrahamson). |
US Patent File History USPN 5,685,867 (Twardowski et al.). |
Number | Date | Country | |
---|---|---|---|
20090204052 A1 | Aug 2009 | US |
Number | Date | Country | |
---|---|---|---|
60980633 | Oct 2007 | US |